Hiroki Nishikawa

19PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyHaematologyMetabolic medicineRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 20, 2026
Baseline DCP May Modify Response to Atezolizumab-Bevacizumab Versus Durvalumab-Tremelimumab in Unresectable HCC.

|May 31, 2026
Safety and Feasibility of Antegrade Cholangiopancreatoscopy-Guided Laser Dissection and Ablation for Pancreaticobiliary Jejunal Anastomotic Stricture (With Video).

|May 23, 2026
Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial.

|Apr 21, 2026
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

|Apr 10, 2026
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab.

Kazunari Tanaka, Kunihiko Tsuji, Atsushi Hiraoka

|Feb 27, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia: Review of Literature.

Hiroki Nishikawa, Soo Ki Kim, Sachiyo Yoshio

Pageof 4

Frequent Collaborators

11 joint publications

Asahiro Morishita

11 joint publications

Toru Ishikawa

11 joint publications

Hidenori Toyoda

11 joint publications

Masanori Atsukawa